View the LUCIBRIGA 180 registration information details.
Back to drug list
ItemsDrug Registration information
ID1696
No1696
Brand NameLUCIBRIGA 180
IngredientsBRIGATINIB 180 MG
Dosage FormTABLET
Primary PackagingBOTTLE
Storage
Shelf Life2 YEARS
Pack SizeBOX OF 30'S/BOTTLE
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsFOR THE TREATMENT OF ADULT PATIENTS WITH ANAPLASTIC LYMPHOMA KINASE-POSITIVE METASTATIC NON SMALL CELL LUNG CANCER
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionWHITE TABLETS, LETTER LUS ON ONE SIDE AND PLAIN ON THE OTHER
Note
License OwnerLUCIUS PHARMACEUTICALS(LAO) CO.,LTD
ManufacturerLUCIUS PHARMACEUTICALS(LAO) CO.,LTD
CountryLAOS
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No02 L 1066/24
FDD Registration Date14/03/2023
Expiry Date13/03/2027
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA